116 related articles for article (PubMed ID: 24119646)
1. Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms.
Guo J; Zou Y; Wu Z; Wu W; Xu Z; Hu H; Huang L; Dong H; Chen J; Lu J; Fu Y; Wang J; Ma Y; Chen X; He F; Yang S; Liao L; Chen J; Zheng F; Tan J
Cytotherapy; 2014 Apr; 16(4):471-84. PubMed ID: 24119646
[TBL] [Abstract][Full Text] [Related]
2. Effects of asiaticoside on levels of podocyte cytoskeletal proteins and renal slit diaphragm proteins in adriamycin-induced rat nephropathy.
Wang Z; Liu J; Sun W
Life Sci; 2013 Sep; 93(8):352-8. PubMed ID: 23871990
[TBL] [Abstract][Full Text] [Related]
3. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
[TBL] [Abstract][Full Text] [Related]
4. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
Zhu Y; Lu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
[TBL] [Abstract][Full Text] [Related]
8. The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats.
Ma H; Wu Y; Zhang W; Dai Y; Li F; Xu Y; Wang Y; Tu H; Li W; Zhang X
Cytotherapy; 2013 Jun; 15(6):703-11. PubMed ID: 23499348
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy.
Wu H; Wang Y; Tay YC; Zheng G; Zhang C; Alexander SI; Harris DC
Kidney Int; 2005 Jun; 67(6):2178-86. PubMed ID: 15882261
[TBL] [Abstract][Full Text] [Related]
10. Steroids and Adriamycin nephrosis.
Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
[TBL] [Abstract][Full Text] [Related]
11. Effects of mesenchymal stem cells transplanted at different time points in a rat remnant kidney model.
Bian X; Zhang B; Guo W; Liu N; Bai Y; Miao J; Zhao G; Liu B; Wang S; Ma L; Zheng L; Zhao Y; Li D; Feng J
Am J Nephrol; 2014; 39(1):75-84. PubMed ID: 24457259
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus.
Ma J; Fan S; Chen J; Gu Y; Lin S
Chin Med J (Engl); 1999 Dec; 112(12):1068-72. PubMed ID: 11721440
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study in renal protective effect of tranilast on rats with adriamycin nephropathy].
Tao Y; Wu X; Li DD; Liu QF; Bo H; Wang XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):76-9. PubMed ID: 18390206
[TBL] [Abstract][Full Text] [Related]
15. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
16. Impact of bone-marrow-derived mesenchymal stem cells on adriamycin-induced chronic nephropathy.
Sarhan M; El Serougy H; Hussein AM; El-Dosoky M; Sobh MA; Fouad SA; Sobh M; Elhusseini F
Can J Physiol Pharmacol; 2014 Sep; 92(9):733-43. PubMed ID: 25093892
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of bone marrow derived mesenchymal stromal cells versus losartan on adriamycin-induced renal cortical injury in adult albino rats.
Anan HH; Zidan RA; Shaheen MA; Abd-El Fattah EA
Cytotherapy; 2016 Aug; 18(8):970-984. PubMed ID: 27378342
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
19. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression.
Liu Y; Ji Z
J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.
Bi X; Zhu G; Han Z; Ye Y; Liang Y; Zhang L; Hao Z; Zeng G; He H; Zhong W
Clin Invest Med; 2009 Jun; 32(3):E229-38. PubMed ID: 19480741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
